Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Mycophenolate mofetil in the treatment of multiple sclerosis: A preliminary report.
Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST).
Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination.
HLA-DRB1*15:01 and multiple sclerosis: a female association?
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients.
T(H)17 cytokines in autoimmune neuro-inflammation.
The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis.
Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.
Scientific discussion for the approval of Masivet
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.
Sex ratio of multiple sclerosis and clinical phenotype.
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.
[Recommendations for a brief international cognitive assessment for multiple sclerosis].
Temporal trends in the incidence of multiple sclerosis: a systematic review.
Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis.
Teriflunomide added to interferon-β in relapsing multiple sclerosis: A randomized phase II trial.
Seeing illness in art and medicine: a patient and printmaker collaboration.
Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations.
Transfer of interferon β-1a into human breastmilk.
Demyelination of the hippocampus is prominent in the cuprizone model.
HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica.
Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.
Long-Term Effects of Exposure to Disease-Modifying Drugs in the Offspring of Mothers with Multiple Sclerosis: A Retrospective Chart Review.
The natural history of primary progressive MS in British Columbia, Canada.
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.

Pages